Ignite Creation Date:
2024-05-05 @ 11:55 AM
Last Modification Date:
2024-10-26 @ 9:16 AM
Study NCT ID:
NCT00170729
Status:
COMPLETED
Last Update Posted:
2017-03-01
First Post:
2005-09-09
Brief Title:
A Study to Compare Ocular Safety and Tolerability of Eye Drops Containing Prednisolone Acetate in Patients With Intraocular Inflammation After Cataract Surgery
Sponsor:
Novartis
Organization:
Novartis
Study Overview
Official Title:
Multi-center Randomized Double Masked Vehicle Controlled Phase IV Study to Compare the Efficacy Ocular Safety and Tolerability of a Two Day Treatment With Eye Drops 05 Prednisolone Acetate One Drop Four Times Per Day in Patients With Intraocular Inflammation After Cataract Surgery Followed by an Open Label Observational Period of 12 Days
Status:
COMPLETED
Status Verified Date:
2017-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The primary objective was to demonstrate that two days of treatment with 05 prednisolone acetate eye-drops after cataract surgery are superior to vehicle in reducing the flare in the anterior chamber of the operated eye
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None